NCT03121833View on ClinicalTrials.gov

Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma

PHASE2CompletedINTERVENTIONAL

Enrollment

52

Participants

Timeline

Start Date

May 1, 2017

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions

Soft Tissue Sarcoma, Adult, Stage IIB

Interventions

DRUG

Endostar

Recombinant Human Endostatin Injection

DRUG

Placebo

500ml 0.9% sodium chloride

DRUG

AIM regimen / GT regimen

"Pirarubicin (THP) + Ifosfamide (IFO) / Docetaxel (TXT) + Gemcitabine (GEM)"

Trial Locations (1)

300060

Tianjin Medical University Cancer Hospital & Institute, Tianjin

All Listed Sponsors

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER

NCT03121833 - Endostar Combined With Chemotherapy for Stage Ⅳ Soft Tissue Sarcoma | Biotech Hunter | Biotech Hunter